With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
In August 2023, a deputy secretary of defense stood before a crowd at the National Defense Industrial Association’s Emerging Technologies conference and laid out a plan to flood the battlefield with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results